ALX Oncology Holdings Inc. Common Stock ALXO
i
Market datapartial · fetched 2026-11-04T00:49:17.588Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T21:00:04.090543024Z
FundamentalsAlpha Vantage · unavailable
ALX Oncology Holdings Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | 1.56 | 294.5% | 18.4% | |||
| 55Δ | 1.40 | 268.9% | 28.6% | 1.63 | 277.3% | 16.0% |
| 60Δ | 1.30 | 288.0% | 25.7% | 1.70 | 260.0% | 13.5% |
| 65Δ | 1.21 | 307.1% | 22.8% | 1.77 | 242.7% | 11.1% |
| 70Δ | 1.12 | 326.3% | 19.9% | 1.84 | 225.4% | 8.7% |
| 75Δ | 1.03 | 345.4% | 17.1% | 1.91 | 208.1% | 6.2% |
| 80Δ | 0.88 | 402.2% | 14.4% | 1.98 | 190.9% | 3.8% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.56
- IV
- 294.5%
- B/E move
- 18.4%
55Δ
- Pseudo strike
- 1.40
- IV
- 268.9%
- B/E move
- 28.6%
- Pseudo strike
- 1.63
- IV
- 277.3%
- B/E move
- 16.0%
60Δ
- Pseudo strike
- 1.30
- IV
- 288.0%
- B/E move
- 25.7%
- Pseudo strike
- 1.70
- IV
- 260.0%
- B/E move
- 13.5%
65Δ
- Pseudo strike
- 1.21
- IV
- 307.1%
- B/E move
- 22.8%
- Pseudo strike
- 1.77
- IV
- 242.7%
- B/E move
- 11.1%
70Δ
- Pseudo strike
- 1.12
- IV
- 326.3%
- B/E move
- 19.9%
- Pseudo strike
- 1.84
- IV
- 225.4%
- B/E move
- 8.7%
75Δ
- Pseudo strike
- 1.03
- IV
- 345.4%
- B/E move
- 17.1%
- Pseudo strike
- 1.91
- IV
- 208.1%
- B/E move
- 6.2%
80Δ
- Pseudo strike
- 0.88
- IV
- 402.2%
- B/E move
- 14.4%
- Pseudo strike
- 1.98
- IV
- 190.9%
- B/E move
- 3.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 210.81% | |
| 240.11% | |
| 218.00% | |
| 267.03% | |
| 271.30% | |
| 201.03% | |
| 304.00% | |
| 255.58% | |
| 193.01% | |
| 207.30% | |
| 260.88% | |
| 189.86% | |
| 223.08% | |
| 179.21% | |
| 201.47% | |
| 169.41% | |
| 158.11% | |
| 222.94% | |
| 225.18% | |
| 215.26% | |
| 218.18% | |
| 244.16% | |
| 276.26% | |
| 283.90% | |
| 247.65% | |
| 247.49% | |
| 238.45% | |
| 293.44% | |
| 301.90% | |
| 324.61% | |
| 282.42% | |
| 287.46% |
Biotechnology
ANAB
AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company…
More →ANIX
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is…
More →ANNX
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases. The company is headquartered in South…
More →ANRO
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos,…
More →ANTX
Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.
More →ARCT
Description unavailable
More →